CN1049789A - The manufacture method of musk-toad bolus - Google Patents
The manufacture method of musk-toad bolus Download PDFInfo
- Publication number
- CN1049789A CN1049789A CN90100889A CN90100889A CN1049789A CN 1049789 A CN1049789 A CN 1049789A CN 90100889 A CN90100889 A CN 90100889A CN 90100889 A CN90100889 A CN 90100889A CN 1049789 A CN1049789 A CN 1049789A
- Authority
- CN
- China
- Prior art keywords
- manufacture method
- toad
- musk
- bolus
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A kind of manufacture method of musk-toad bolus belongs to the method for making of medicine.
The present invention has worked out a kind of manufacture method for the treatment of cancer drug, it is characterized in that Scorpio, Scolopendra parch yellowly and an amount of Moschus and Bufo siccus are mixed fine grinding, sieves, and reconciles into ball with Mel.Through clinical trial to cancer as: pulmonary carcinoma, gastric cancer, advanced esophageal cancer patient have significant curative effect.
Description
The present invention relates to a kind of manufacture method for the treatment of the medicine of cancer.
The cancer patient reaches an advanced stage and is difficult to cure at present, such as the end-stage patients of pulmonary carcinoma, gastric cancer, esophageal carcinoma, does not also have highly effective medicine can cure this patients with terminal.
The objective of the invention is to work out a kind of manufacture method for the treatment of cancer drug, the Moschus toad that produces with the present invention
Ball has very significant curative effect to above-mentioned several Advanced Carcinoma Patient, and cure rate is more than 90%.
Manufacture method of the present invention is as follows:
At first Scorpio, Scolopendra are gone up a pot parch respectively, the temperature of pot can not be too high, often stirs, and treats that these two kinds of medicines all fry yellowly and take out and to cool, then with the Moschus of total dose 1-2% and the toad of 10-15%
Mix, fine grinding on little mill is sieved, and remaining disintegrating slag grinds and rescreens, and till whole medicines all sieve into smalls, stirs, and is mixed into piller with Mel, promptly makes the Moschus toad
Ball.Sooner or later respectively obey the 20-30 grain, a week is a course of treatment.
Through clinical trial, the end-stage patients of 11 routine pulmonary carcinoma, gastric cancer, esophageal carcinoma are taken this medicine.Except that 1 routine patient because of in advance through chemotherapeutic treatment invalid, all the other 10 examples are all complete.
An osteocarcinoma patient takes this medicine and also obtains obvious curative effects.
With the medicine that the present invention makes, make simply, taking convenience, evident in efficacy.
Still can make injection through strict sterilization except pill, injection for intravenous is used.
Three Example formulations of the present invention are as follows
Nomenclature of drug percentage by weight percentage by weight percentage by weight
Scolopendra 40% 42% 40%
Scorpio 46.5% 46% 44%
Moschus 1.5% 2% 1%
Toad
12% 10% 15%
Grinding smalls taking-up 5 grams that as stated above and close the sweet ball that is, make 420 altogether, is the maximum consumption of a course of treatment.
Claims (2)
1, a kind of manufacture method of musk-toad bolus is characterized in that: an amount of Scorpio, Scolopendra are gone up the pot parch respectively, through repeatedly stirring, treat its yellowly, taking-up cools, and mixes fine grinding on little mill with the Bufo siccus of the 10-15% of total dose of the Moschus of total dose 1-2%, sieve, remaining disintegrating slag grinds again, rescreens, and all sieves into smalls up to whole medicines, stir, close ball with Mel.
2, the manufacture method of musk-toad bolus as claimed in claim 1 is characterized in that: the pot employing crucible of parch Scorpio and Scolopendra.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN90100889A CN1049789A (en) | 1990-02-24 | 1990-02-24 | The manufacture method of musk-toad bolus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN90100889A CN1049789A (en) | 1990-02-24 | 1990-02-24 | The manufacture method of musk-toad bolus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1049789A true CN1049789A (en) | 1991-03-13 |
Family
ID=4876847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN90100889A Pending CN1049789A (en) | 1990-02-24 | 1990-02-24 | The manufacture method of musk-toad bolus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1049789A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1062446C (en) * | 1994-03-23 | 2001-02-28 | 蔡航翔 | Anti-allergy disease preparation |
| CN102416083A (en) * | 2011-12-12 | 2012-04-18 | 许从玉 | Medicinal composition for treating esophagus cancer |
| CN102526447A (en) * | 2012-02-09 | 2012-07-04 | 周淦其 | Manufacturing method of external medicine for treating low rectal cancer |
| CN102526200A (en) * | 2010-12-27 | 2012-07-04 | 包桂荣 | Compound traditional Chinese medicine preparation for treating cancer of esophagus and production method thereof |
| CN102526115A (en) * | 2007-10-28 | 2012-07-04 | 郭桂芹 | Medicament for treating and preventing immune diseases and cancers |
| CN102920829A (en) * | 2012-11-28 | 2013-02-13 | 陈丽芳 | Drug for treating psoriasis and preparation method thereof |
| CN105148011A (en) * | 2015-08-25 | 2015-12-16 | 重庆林祥生物技术有限公司 | Cancer-curing transdermal cream and preparation method thereof |
| CN108567858A (en) * | 2018-05-18 | 2018-09-25 | 杜美丽 | A kind of antitumor Chinese and conformal positioning local penetration therapy |
| CN110279722A (en) * | 2019-07-23 | 2019-09-27 | 韩学民 | A kind of Chinese medicine and its preparation method and application for treating tuberculosis |
-
1990
- 1990-02-24 CN CN90100889A patent/CN1049789A/en active Pending
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1062446C (en) * | 1994-03-23 | 2001-02-28 | 蔡航翔 | Anti-allergy disease preparation |
| CN102526115A (en) * | 2007-10-28 | 2012-07-04 | 郭桂芹 | Medicament for treating and preventing immune diseases and cancers |
| CN102526115B (en) * | 2007-10-28 | 2015-02-25 | 郭桂芹 | Medicament for treating and preventing immune diseases and cancers |
| CN102526200A (en) * | 2010-12-27 | 2012-07-04 | 包桂荣 | Compound traditional Chinese medicine preparation for treating cancer of esophagus and production method thereof |
| CN102416083A (en) * | 2011-12-12 | 2012-04-18 | 许从玉 | Medicinal composition for treating esophagus cancer |
| CN102416083B (en) * | 2011-12-12 | 2012-07-18 | 许从玉 | Medicinal composition for treating esophagus cancer |
| CN102526447A (en) * | 2012-02-09 | 2012-07-04 | 周淦其 | Manufacturing method of external medicine for treating low rectal cancer |
| CN102526447B (en) * | 2012-02-09 | 2013-09-04 | 周淦其 | Manufacturing method of external medicine for treating low rectal cancer |
| CN102920829A (en) * | 2012-11-28 | 2013-02-13 | 陈丽芳 | Drug for treating psoriasis and preparation method thereof |
| CN105148011A (en) * | 2015-08-25 | 2015-12-16 | 重庆林祥生物技术有限公司 | Cancer-curing transdermal cream and preparation method thereof |
| CN108567858A (en) * | 2018-05-18 | 2018-09-25 | 杜美丽 | A kind of antitumor Chinese and conformal positioning local penetration therapy |
| CN110279722A (en) * | 2019-07-23 | 2019-09-27 | 韩学民 | A kind of Chinese medicine and its preparation method and application for treating tuberculosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2813017B2 (en) | How to reduce side effects of cancer therapy | |
| CN1049789A (en) | The manufacture method of musk-toad bolus | |
| HU206834B (en) | Process for producing pharmaceutical compositions containing interferone and/or tumor necrosis factor for treating systhematically preneoplastic lesions | |
| Seo et al. | Mucoepidermoid carcinoma of the bronchus in a 4‐year‐old child. A high‐grade variant with lymph node metastasis | |
| RU2202361C2 (en) | Lectin-containing composites and their usage | |
| Rosso et al. | Effect of granulocyte-macrophage colony-stimulating factor on prevention of mucositis in head and neck cancer patients treated with chemo-radiotherapy | |
| CN107096028B (en) | Ultra-small particle size semimetal nanoparticle material and preparation method thereof | |
| Langdon et al. | Oral cancer and sex why do females do better? | |
| CN104771431B (en) | Chinese herbal medicine powder composition and preparation method thereof | |
| CN100398113C (en) | Nano selenium of Melatonin and its preparation method | |
| CN1034908C (en) | Preparation method of external ointment | |
| Magnusson et al. | Interferon therapy in recurrent renal carcinoma | |
| LindeløSv et al. | Squamous Cell Carcinoma of the Oral Cavity: An unselected material from a 5-year period | |
| US5895665A (en) | Powdered stone mineral supplement | |
| CN107596003A (en) | Treat ointment of skin injury and preparation method thereof | |
| CN115612902B (en) | Magnesium-based alloy microparticles with synergistic TACE (tar-based) liver cancer resisting effect and preparation method thereof | |
| CN1031173C (en) | Process for producing bioactive material, and product therefrom | |
| KR100518126B1 (en) | Lectin composition and its use | |
| CN1359671A (en) | Process for preparing tablet for quickly setting up bone | |
| KR100452007B1 (en) | Mineral powder having inhibition effect of cancer cell proliferation | |
| CN111529626A (en) | A Chinese medicinal composition for treating gastrointestinal diseases, and its preparation method | |
| CN1092982A (en) | Ulcer ointment for external use | |
| CN1084065A (en) | Fitness and anti-cancer medicated bra drug core preparation technology | |
| US20220000910A1 (en) | Use of mutant p53 gene targeted lead borate nanoparticles in cancer treatment and production method of these nanoparticles | |
| WO2015090139A1 (en) | Antitumor drug, preparation method and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |